Capecitabine

ATC Code L01BC06

Capecitabine

Definition

A fluoropyrimidine carbamate belonging to the class of antineoplastic agents called antimetabolites. As a prodrug, capecitabine is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU); subsequently, 5-FU is metabolized to two active metabolites, 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP) by both tumor cells and normal cells. FdUMP inhibits DNA synthesis and cell division by reducing normal thymidine production, while FUTP inhibits RNA and protein synthesis by competing with uridine triphosphate for incorporation into the RNA strand. (NCI04)

Also known as 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-cytidine, CAPECITABINE, Ro 09-1978/000, Xeloda — per NCIT

Also identified as

Indications

Disease Relation Source
Breast neoplasm may treat MEDRT · Public domain (U.S. Government work)
Colorectal neoplasm may treat MEDRT · Public domain (U.S. Government work)